BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20132187)

  • 1. Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions.
    Giaginis C; Zarros A; Alexandrou P; Klijanienko J; Delladetsima I; Theocharis S
    APMIS; 2010 Mar; 118(3):210-21. PubMed ID: 20132187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions.
    Lakiotaki E; Giaginis C; Tolia M; Alexandrou P; Delladetsima I; Giannopoulou I; Kyrgias G; Patsouris E; Theocharis S
    Biomed Res Int; 2015; 2015():839403. PubMed ID: 26539529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.
    Wiseman SM; Griffith OL; Melck A; Masoudi H; Gown A; Nabi IR; Jones SJ
    Am J Surg; 2008 May; 195(5):667-73; discussion 673. PubMed ID: 18424286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
    Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
    Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
    Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients.
    Jee YS; Lee SG; Lee JC; Kim MJ; Lee JJ; Kim DY; Park SW; Sung MW; Heo DS
    Anticancer Res; 2002; 22(5):2629-34. PubMed ID: 12529974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
    Giaginis C; Alexandrou P; Poulaki E; Delladetsima I; Troungos C; Patsouris E; Theocharis S
    Pathol Oncol Res; 2016 Apr; 22(2):269-75. PubMed ID: 26220827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NM23 protein in neoplastic and nonneoplastic thyroid tissues.
    Bertheau P; De La Rosa A; Steeg PS; Merino MJ
    Am J Pathol; 1994 Jul; 145(1):26-32. PubMed ID: 8030752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of farnesoid X receptor expression in thyroid neoplasia.
    Giaginis C; Tsoukalas N; Alexandrou P; Tsourouflis G; Dana E; Delladetsima I; Patsouris E; Theocharis S
    Future Oncol; 2017 Aug; 13(20):1785-1792. PubMed ID: 28762281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of the coxsackievirus and adenovirus receptor increases susceptibility to adenoviral infection in the human cervical cancer cell line, SiHa.
    Kim JS; Lee SH; Cho YS; Kim YH; Lee JH
    Biochem Biophys Res Commun; 2001 Oct; 288(1):240-4. PubMed ID: 11594779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.
    Rauen KA; Sudilovsky D; Le JL; Chew KL; Hann B; Weinberg V; Schmitt LD; McCormick F
    Cancer Res; 2002 Jul; 62(13):3812-8. PubMed ID: 12097294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.